Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Children’s use of pseudoephedrine

This article was originally published in The Tan Sheet

Executive Summary

Children younger than 2 years old are often given pseudoephedrine products, according to a study in the Dec. 1 Pediatrics journal. Researchers with the Slone Epidemiology Center at Boston University found 214 out of 4,267 children under the age of 17 surveyed between 1999 and 2006 took pseudoephedrine products - mostly in the form of multiple-ingredient liquids (58.9 percent) and multiple-ingredient tablets (24.7 percent). Use has declined since the institution of the 2005 Combat Methamphetamine Epidemic Act, researchers add
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS102406

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel